Cybin to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Rhea-AI Summary

Cybin Inc. (AMEX:CYBN) announced participation by CEO Doug Drysdale in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022, at 8:40 a.m. ET. The event will highlight the company’s focus on transforming psychedelics into therapeutics for mental health issues. A webcast will be available for those interested in listening to the discussion. Cybin, operational in Canada, the US, UK, and Ireland, is committed to the development of innovative therapeutic solutions leveraging proprietary drug discovery platforms.

TORONTO--(BUSINESS WIRE)--

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics^TM” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022 at 8:40 a.m. ET.

To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005233/en/

Investor & Media:

Leah Gibson

Vice President, Investor Relations

Cybin Inc.

leah@cybin.com

Source: Cybin Inc.

FAQ

When will Doug Drysdale speak at the Oppenheimer 32nd Annual Healthcare Conference?

Doug Drysdale will speak on March 16, 2022, at 8:40 a.m. ET.

What is Cybin Inc.'s stock symbol?

Cybin Inc.'s stock symbol is CYBN.

Where can I listen to the Cybin conference presentation?

You can listen to the presentation via the webcast link provided in the press release.

What is the focus of Cybin Inc.?

Cybin Inc. focuses on developing therapeutics from psychedelics to address mental health issues.

In which countries does Cybin Inc. operate?

Cybin Inc. operates in Canada, the United States, the United Kingdom, and Ireland.